imatinib mesylate has been researched along with Subarachnoid Hemorrhage in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 6 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujimoto, M; Imanaka-Yoshida, K; Shiba, M; Suzuki, H; Taki, W; Yoshida, T | 1 |
Krafft, PR; Lekic, T; Ma, Q; Souvenir, R; Tang, J; Zhan, Y; Zhang, JH | 1 |
Fujimoto, M; Imanaka-Yoshida, K; Kanamaru, K; Kawakita, F; Shiba, M; Suzuki, H; Taki, W; Yoshida, T | 1 |
Changlong, Z; Guangwei, Z; Xiaochuan, S; Xiaohui, X; Xuenong, H; Yanfeng, X | 1 |
Fujimoto, M; Imanaka-Yoshida, K; Kanamaru, K; Matsushima, S; Shiba, M; Shimojo, N; Suzuki, H; Taki, W; Yoshida, T | 2 |
6 other study(ies) available for imatinib mesylate and Subarachnoid Hemorrhage
Article | Year |
---|---|
Tenascin-C causes neuronal apoptosis after subarachnoid hemorrhage in rats.
Topics: Animals; Apoptosis; Benzamides; Disease Models, Animal; Imatinib Mesylate; Neurons; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Rats; Rats, Sprague-Dawley; Subarachnoid Hemorrhage; Tenascin; Vasospasm, Intracranial | 2014 |
Imatinib preserves blood-brain barrier integrity following experimental subarachnoid hemorrhage in rats.
Topics: Animals; Benzamides; Blood-Brain Barrier; Brain Edema; Capillary Permeability; Disease Models, Animal; Imatinib Mesylate; Immunoprecipitation; Male; MAP Kinase Kinase 4; Neurologic Examination; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins pp60(c-src); Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor, Platelet-Derived Growth Factor alpha; Subarachnoid Hemorrhage | 2015 |
Effects of tenascin-C on early brain injury after subarachnoid hemorrhage in rats.
Topics: Animals; Benzamides; Brain Injuries; Disease Models, Animal; Imatinib Mesylate; In Situ Nick-End Labeling; Male; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Rats, Sprague-Dawley; Subarachnoid Hemorrhage; Tenascin; Up-Regulation | 2015 |
The Role of Platelet-Derived Growth Factor Receptor in Early Brain Injury Following Subarachnoid Hemorrhage.
Topics: Animals; Anthracenes; Antineoplastic Agents; Brain Edema; Brain Injuries; Caspase 3; Disease Models, Animal; Double-Blind Method; Enzyme Inhibitors; Gene Expression Regulation; Hippocampus; Imatinib Mesylate; In Situ Nick-End Labeling; Male; Platelet-Derived Growth Factor; Rats; Rats, Sprague-Dawley; Receptors, Platelet-Derived Growth Factor; RNA, Messenger; Subarachnoid Hemorrhage | 2016 |
Imatinib mesylate prevents cerebral vasospasm after subarachnoid hemorrhage via inhibiting tenascin-C expression in rats.
Topics: Animals; Benzamides; Disease Models, Animal; Imatinib Mesylate; Male; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Rats; Rats, Sprague-Dawley; Subarachnoid Hemorrhage; Tenascin; Vasospasm, Intracranial | 2012 |
Role of platelet-derived growth factor in cerebral vasospasm after subarachnoid hemorrhage in rats.
Topics: Animals; Benzamides; Carbon; Carotid Artery, Internal; Coronary Angiography; Disease Models, Animal; Drug Administration Schedule; Enzyme Inhibitors; Gene Expression Regulation; Imatinib Mesylate; Male; Neurologic Examination; Piperazines; Platelet-Derived Growth Factor; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor, Platelet-Derived Growth Factor beta; Subarachnoid Hemorrhage; Vasospasm, Intracranial | 2013 |